Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on January 5, 2006
J Am Soc Nephrol 17: 465-474, 2006
© 2006 American Society of Nephrology
doi: 10.1681/ASN.2005020164

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2005020164v1
17/2/465    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zheng, G.
Right arrow Articles by Harris, D. C.H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zheng, G.
Right arrow Articles by Harris, D. C.H.

Basic Immunology and Pathology

DNA Vaccination with CCL2 DNA Modified by the Addition of an Adjuvant Epitope Protects against "Nonimmune" Toxic Renal Injury

Guoping Zheng*, Yiping Wang*, Shi-Hua Xiang§, Yuet-Ching Tay*, Huiling Wu{dagger},{ddagger}, Debbie Watson{dagger}, Jason Coombes*, Gopala K. Rangan*, Stephen I. Alexander{dagger} and David C.H. Harris*

* Centre for Transplantation and Renal Research, the University of Sydney at Westmead Millenium Institute; {dagger} Centre for Kidney Research, the Children’s Hospital at Westmead; {ddagger} Department of Renal Medicine, Royal Prince Alfred Hospital, University of Sydney, Sydney, New South Wales, Australia; and § Department of Cancer Immunology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts

Address correspondence to: Dr. Guoping Zheng, Centre for Transplantation and Renal Research, University of Sydney at Westmead Millenium Institute, Westmead, Sydney, NSW 2145 Australia. Phone: +61-2-9845-8906; Fax: +61-2-9633-9351; guoping_zheng{at}wmi.usyd.edu.au

Received for publication February 13, 2005. Accepted for publication November 25, 2005.

CC-chemokine-encoding DNA vaccine has been reported to be capable of inducing immunologic memory to corresponding pathogenic self CC-chemokines in animal models of autoimmune disease. This study investigated whether introduction of a foreign T helper epitope into monocyte chemoattractant protein 1 (CCL2) DNA vaccine could boost its immunogenicity by inducing strong neutralizing autoantibody against the pathogenic chemokine CCL2 sufficiently to be protective in a classically nonimmune model of disease, Adriamycin nephropathy (AN). Modification of the CCL2 DNA vaccine by replacing a surface loop region of CCL2 sequence with tetanus toxoid T helper epitope P30 elicited a strong self-specific CCL2 autoantibody production, as well as an IFN-{gamma}–producing T cell cellular response. The increased immunogenicity of modified CCL2 DNA vaccination but not unmodified CCL2 DNA vaccination was protective against functional and structural renal injury in rat AN. The protective effect of the modified CCL2 DNA vaccine was associated with blockade of glomerular and interstitial macrophage recruitment by neutralizing autoantibody against CCL2, which plays a critical role in eliciting renal injury in AN. Therefore, modification with a foreign T helper epitope breaks self-tolerance by inducing a cellular and humoral response against self-protein and provides a strategy to increase the potency of DNA vaccination sufficiently to afford protection in toxin-induced chronic renal disease.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
Y. Wang, Y. Wang, Q. Cai, G. Zheng, V. W.S. Lee, D. Zheng, X. Li, T. K. Tan, and D. C.H. Harris
By Homing to the Kidney, Activated Macrophages Potently Exacerbate Renal Injury
Am. J. Pathol., June 1, 2008; 172(6): 1491 - 1499.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP